Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are having surgery for endometriosis and have significant pain (a pain score of 4 or higher out of 10) — this applies to the "cases" group
- Alternatively, you are having surgery for endometriosis related to fertility problems and have little or no pain (a pain score below 4 out of 10) — this applies to the "controls" group
- You are over 18 years old
- You have agreed to take part and signed a consent form
- You had an MRI scan before your surgery and there is no medical reason preventing you from having a special type of scan called an [18F]-FES PET/CT scan (confirm with trial site)
- Your surgery took place at a specific point in your menstrual cycle (mid-cycle)
- You are covered by a social security or health insurance scheme (confirm with trial site)
Who may not be able to join:
- You are being treated for endometriosis without having surgery
- You are currently pregnant
- You are currently taking any hormone therapy
- You have gone through menopause
- You have a known allergy or sensitivity to the scan substance used (Fluoroestradiol (18F)) or any of its ingredients
- You are under any form of legal guardianship or protection (confirm with trial site)
- You experience significant anxiety in enclosed spaces (claustrophobia), which may affect your ability to have the scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ariane WEYL, MD, University Hospital, Toulouse
Phone: 05 61 32 21 48
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quantification of Estrogen Receptor Overexpression in Endometriotic Lesions Using SUV on [18F]-FES PET/CT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.